Fight Against Fentanyl Act
- Sponsor
- Rep. Kean, Thomas H. [R-NJ-7]
- Committees
- Judiciary Committee (primary)
- Last action
- Oct 1, 2026
Bottom line
This bill expands the permissible uses of existing federal Byrne JAG funds to include the purchase of fentanyl testing kits and opioid reversal agents, providing more flexibility for local anti-opioid efforts.
What it actually does
This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to explicitly allow recipients of the Edward Byrne Memorial Justice Assistance Grant (Byrne JAG) to use these federal funds for purchasing fentanyl testing kits and opioid reversal agents. This expands the permissible uses of existing grant money, providing state and local law enforcement and first responders with more flexibility to acquire tools to combat the opioid crisis.
Proponents argue
Proponents argue that this bill provides critical flexibility to state and local law enforcement and first responders, allowing them to directly address the immediate dangers of the opioid crisis by funding essential tools like fentanyl testing kits and life-saving opioid reversal agents. They contend that this will empower communities to better protect both their officers and the public from accidental exposure and overdose, aligning law enforcement efforts with public health needs.
Opponents contend
Opponents might argue that while the goal is laudable, this bill could dilute the primary focus of Byrne JAG funds, which are intended for a broad range of criminal justice programs. They might express concern that diverting funds for these specific purchases could reduce resources available for other critical law enforcement needs, such as crime prevention, training, or technology upgrades, without providing new dedicated funding.
The bill is exceptionally short and straightforward, making it very accessible for any reader to understand its core purpose quickly.
Section 2
Expansion of Byrne JAG Grant Permissible Uses
This section amends Section 501(a)(1)(E) of title I of the Omnibus Crime Control and Safe Streets Act of 1968. It explicitly adds 'including programs to purchase fentanyl testing kits and opioid reversal agents' to the list of permissible uses for the Edward Byrne Memorial Justice Assistance Grant (Byrne JAG) funds. This means that state and local agencies receiving these federal grants can now officially allocate funds towards acquiring these specific items to address the opioid epidemic.
Supporters argue
Supporters argue that explicitly allowing Byrne JAG funds for fentanyl testing kits and opioid reversal agents is a practical and necessary step to equip frontline personnel with essential tools to combat the opioid epidemic. They highlight the dual benefit of protecting officers from accidental exposure and enabling them to save lives in overdose situations, aligning law enforcement efforts with public health needs.
Critics contend
Critics might contend that while these tools are valuable, explicitly earmarking Byrne JAG funds for them could inadvertently shift resources away from other critical criminal justice priorities that the grant is designed to support, such as violent crime reduction, community policing, or correctional programs. They might argue that new, dedicated funding streams would be more appropriate for these specific public health interventions.
Tradeoffs
The primary tension involves balancing the need to address the immediate opioid crisis with the broader objectives of the Byrne JAG program. While the bill provides flexibility, it also raises questions about whether these specific uses might compete with other established criminal justice priorities for the same pool of funds.